Patent 7655775 was granted and assigned to CanBiocin Inc. on February, 2010 by the United States Patent and Trademark Office.
The present invention is compositions and methods for producing anti-bacterial polypeptides, and for using those compositions and methods for treating diseases and conditions caused by a bacterial infection. More specifically, the compositions and methods include treating a gram-negative bacterium with a gram-positive host that produces a polypeptide effective against the gram-negative bacterium.